NP_001162444.1
[Other Products]
NCBI GenBank Nucleotide #
|
[Other Products]
UniProt Primary Accession #
|
[Other Products]
UniProt Related Accession #
Molecular Weight
86,269 Da
NCBI Official Full Name
exostosin-1
NCBI Protein Information
exostosin-1; exostoses 1; Multiple exostoses protein 1 homolog; Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase
UniProt Protein Name
Exostosin-1
UniProt Synonym Protein Names
Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase; Multiple exostoses protein 1 homolog
UniProt Entry Name
EXT1_PAPAN
UniProt Comments for EXT1
Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Required for the exosomal release of SDCBP, CD63 and syndecan ().
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Diseases associated with EXT1 recombinant protein
Disease Name |
Pubmed Publications |
EXOSTOSES, MULTIPLE, TYPE I Antibodies |
>171 publications with EXT1 and EXOSTOSES, MULTIPLE, TYPE I |
Exostoses, Multiple Hereditary Antibodies |
>171 publications with EXT1 and Exostoses, Multiple Hereditary |
Chondrosarcoma Antibodies |
>35 publications with EXT1 and Chondrosarcoma |
Nervous System Diseases Antibodies |
>10 publications with EXT1 and Nervous System Diseases |
Disease Models, Animal Antibodies |
>10 publications with EXT1 and Disease Models, Animal |
Adenocarcinoma Antibodies |
>5 publications with EXT1 and Adenocarcinoma |
Breast Neoplasms Antibodies |
>5 publications with EXT1 and Breast Neoplasms |
Cell Transformation, Neoplastic Antibodies |
>4 publications with EXT1 and Cell Transformation, Neoplastic |
Liver Diseases Antibodies |
>4 publications with EXT1 and Liver Diseases |
Hypertrophy Antibodies |
>4 publications with EXT1 and Hypertrophy |
Organs/Tissues associated with EXT1 recombinant protein
|